SLC4A1 and hypertensive disorder: These findings were similar to those obtained with SAO and PAO, whereas these preparations could attenuate BP in a genetic rat model of human HTN and deoxycorticosterone acetate (DOCA) salt-induced HTN, respectively [6,8].